Dermatophagoides siboney allergen components (D. siboney allergens)

Dermatophagoides siboney allergen components are a group of proteins derived from the house dust mite species D. siboney, which is prevalent in tropical and subtropical regions such as the Caribbean. These allergens, most notably the major allergens Der s 1 (a cysteine protease) and Der s 2 (an NPC2 family protein), are potent triggers of Type I hypersensitivity reactions in sensitized individuals. They function biologically as enzymes or lipid-binding proteins within the mite's digestive system but act as environmental antigens that cross-link IgE on the surface of mast cells and basophils in humans. This interaction leads to the release of inflammatory mediators, resulting in clinical manifestations such as allergic asthma, rhinitis, and atopic dermatitis (Source: PMID: 9544833, World Allergy Organization). In a therapeutic context, these allergen components are the primary constituents of allergen-specific immunotherapy (AIT) products, such as the standardized extract VALERGEN-S. The goal of such therapy is to desensitize the patient's immune system through controlled exposure, promoting the production of blocking antibodies (IgG4) and regulatory T cells. Understanding the component-resolved profile of D. siboney is critical for effective diagnosis and treatment, as there is significant cross-reactivity with other Dermatophagoides species like D. pteronyssinus and D. farinae, yet D. siboney possesses unique epitopes that require specific therapeutic intervention (Source: PMID: 11503854, PMID: 25633145).

Other names

House dust mite allergens (Dermatophagoides siboney)Der s allergensCuban house dust mite allergens

Allergen immunotherapy (AIT) involves the repeated administration of specific allergen extracts to induce immune tolerance by shifting the immune response from a Th2-mediated IgE production to a Th1/Treg-mediated response, increasing IgG4 levels and reducing mast cell/basophil degranulation (Source: PMID: 29055350, PMID: 11503854).